WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (“SRLS”) today announced that its joint plan of reorganization (the “Plan”) has become effective and SeraCare has emerged from its Chapter 11 bankruptcy proceeding. The Plan, which was previously approved by the United States Bankruptcy Court for the Southern District of California, allows SeraCare to pay off all its creditors in full and exit bankruptcy under the ownership of its existing shareholders. The Plan also provides for the settlement of SeraCare’s alleged liabilities in the previously filed shareholders’ class action lawsuit.
